TP53 and cancer: This study used a combination of NMDi and XR-2 in MDM2-overexpressed TP53 wild-type cancer cells and synergistically promoted cell apoptosis and DNA repair, inhibited cell-cycle progression and suppressed cell proliferation (Fig. 7).